Food News and Research

RSS

BioNano Genomics' IrysChip V2 named Top 10 Innovations of 2014

BioNano Genomics, the leader in genome mapping, announced today that The Scientist named the Company's IrysChip™ V2 one of the Top 10 Innovations of 2014.

1 Dec 2014

Grand Challenges Canada announces $1.2 million in grant for 11 new global health innovations

Grand Challenges Canada, funded by the Government of Canada, today announced $1.2 million in funding for 11 new global health innovations implemented in member states of La Francophonie.

29 Nov 2014

Health Canada warns Canadians against illegal health products

A vendor in Atlantic Canada (www.health-recovery-info.com) is selling Miracle Mineral Solution (MMS), an unauthorized drug product which Health Canada has previously warned may pose serious risks to health if ingested.

29 Nov 2014

Pivotal Therapeutics announces accomplishments, financial results for Q3 2014

Pivotal Therapeutics Inc., ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced its accomplishments and financial results for the three months ended September 30, 2014.

29 Nov 2014

FDA takes immediate steps to help reduce risk of spreading unsuspected uterine cancer

The U.S. Food and Drug Administration is taking immediate steps to help reduce the risk of spreading unsuspected cancer in women being treated for uterine fibroids, which is in keeping with Kalorama Information's view that in the female health market there is much room for improvement both in the development of products and the treatment of diseases.

29 Nov 2014

ImaCor releases all-in-one platform for advanced hemodynamic management

ImaCor, Inc, the developer of the world’s first and only hemodynamic transesophageal echocardiography (hTEE) technology, today announced the release of its all-in-one platform for advanced hemodynamic management.

29 Nov 2014

Researchers investigate FDA influence for improving pivotal drug studies

An examination of the potential interaction between pharmaceutical companies and the U.S. Food and Drug Administration (FDA) to discuss future studies finds that one-quarter of recent new drug approvals occurred without any meeting, and when such meetings occurred, pharmaceutical companies did not comply with one-quarter of the recommendations made by the FDA regarding study design or primary outcome, according to a study in the November 26 issue of JAMA.

28 Nov 2014

Runners, walkers come together to participate in 3rd annual Thanksgiving Day 5K

Over 2,300 running enthusiasts and members of the community came together to participate in the third annual Thanksgiving Day 5K. Thousands of crew, volunteers and spectators supported the racers along the 3.1 mile route.

28 Nov 2014

Study highlights need for holistic approach to make foods and diets healthier

How can research in food and diets address how we will live and eat in 2050? By supporting the move towards individualised diets; by ensuring the sustainability of the future food system; by improving our understanding of links between food, nutrients and health; and by focusing on integrated policy-making.

28 Nov 2014

Assessing patient's decision-making capacity

Physicians often find it hard to tell if a patient suffering from dementia or depression is capable of making sound judgements. This is shown by a study conducted within the scope of the National Research Programme "End of Life" (NRP 67). The Central Ethics Committee of the Swiss Academy of Medical Sciences now aims to elaborate new assessment principles.

28 Nov 2014

Improving dietary fiber content in bread

There are two main types of bread, wholemeal, or brown, and white. But most people in Europe prefer white bread. That is a problem because white bread contains very little fibres. And the lack of dietary fibres in the European diet causes serious diseases like diabetes, obesity and even cancer.

27 Nov 2014

Hovione submits first IND Application with FDA for minocycline gel

Hovione announced today it has filed its first Investigational New Drug (IND) Application with the U.S. Food and Drug Administration. This event represents a milestone in Hovione's strategy of developing improved drug delivery options for established drugs.

27 Nov 2014

Leading medical experts across the UK call for radical scale up of liver disease treatment

Leading medical experts today [Thursday 27 November] warn that rising numbers of deaths from liver disease - already the UK's third commonest cause of premature death - will be unavoidable without radical improvements in treatment and detection services, and tougher government policies to control the excessive alcohol use and obesity responsible for much of the national burden of liver disease.

27 Nov 2014

FDA issues Complete Response letter for Avanir’s AVP-825 NDA

Avanir Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response letter to its New Drug Application (NDA) for AVP-825.

27 Nov 2014

Interventional X-ray guidance device may reduce radiation exposure of liver cancer patients

Johns Hopkins researchers report that their test of an interventional X-ray guidance device approved by the U.S. Food and Drug Administration in 2013 has the potential to reduce the radiation exposure of patients undergoing intra-arterial therapy (IAT) for liver cancer.

27 Nov 2014

Consumers make more healthful choices of foods using nutrition labels

A recent study by Professor Monique Raats of the University of Surrey's Food, Consumer Behaviour and Health Research Centre, in conjunction with the European Food Information Council in Brussels, has shown that consumers do take into account reference amounts displayed on front of pack nutrition labelling when making their judgements of healthfulness, thus highlighting their importance for the effective presentation of nutrition information.

26 Nov 2014

TFAH applauds FDA for releasing new nutritional labeling rules

Trust for America's Health applauds the U.S. Food and Drug Administration for releasing two final rules establishing nutritional labeling requirements for menu items sold in retail food establishments and in vending machines.

26 Nov 2014

FDA-approved therapy could be effective in older, African American patients with lung cancer

University of Cincinnati researchers have found in a phase-2 clinical trial that a Food and Drug Administration-approved therapy could be effective in treating both older and African American patients with advanced lung cancer who may not be candidates for chemotherapy.

26 Nov 2014

Study sheds light on how animals regulate body size

The proper regulation of body size is of fundamental importance, but the mechanisms that stop growth are still unclear. In a study now published in the scientific journal eLife, a research group from Instituto Gulbenkian de Ciência (IGC), led by Christen Mirth, shed new light on how animals regulate body size.

26 Nov 2014

Janssen submits YONDELIS NDA for treatment of advanced soft tissue sarcoma

PharmaMar announces that Janssen Research & Development, LLC has submitted a New Drug Application (NDA) for YONDELIS (trabectedin) to the U.S. Food and Drug Administration for the treatment of patients with advanced soft tissue sarcoma (STS), including liposarcoma and leiomyosarcoma subtypes, who have received prior chemotherapy including an anthracycline.

26 Nov 2014